O 2 Hb by 2.2 ± 1.2 μmol (p < 0.05 vs. resting normoxia); hypoxic exercise further lowered it to −7.6 ± 3.1 μmol below baseline (p < 0.05). cerebral HHb, increased by 3.5 ± 1.8 μmol in resting hypoxia (p < 0.05), and further to 8.5 ± 2.9 μmol in hypoxic exercise (p < 0.05). changes in cBF and cerebral tissue oxygenation during rt did not correlate with tt performance loss (R = 0.4, p > 0.05 and R = 0.5, p > 0.05, respectively), while tissue oxygenation and SaO 2 changes during tt did (R = −0.76, p < 0.05). Significant correlations were observed between SaO 2 , McAv and HHb during rt (R = −0.77, −0.76 and 0.84 respectively, p < 0.05 in all cases). Conclusions cBF and cerebral tissue oxygenation changes during rt do not predict performance impairment in hypoxia. Since the changes in SaO 2 and brain HHb during the tt correlated with performance impairment, the hypothesis that brain oxygenation plays a limiting role for global exercise in conditions of severe hypoxia remains to be tested further.
studies: first, people with higher V O 2 peak in normoxia are more adversely affected (Martin and O'Kroy 1993; gore et al. 1996; Ferretti et al. 1997; Woorons et al. 2007 ; calbet and lundby 2009); and second, this is due to a greater drop in arterial oxygen saturation (SaO 2 ), arterial oxygen content (caO 2 ), and mass O 2 transport (Ekblom et al. 1975; chapman et al. 1999; Woorons et al. 2007 ; calbet and lundby 2009), leading to an early onset of muscle fatigue and exhaustion (Amann and Kayser 2009 ). In moderate hypoxia, maximum cardiac output is similar to that in normoxia, which supports the notion that mass cardiovascular oxygen transport is a main limiting factor. But in more severe hypoxia (SaO 2 < 75 %), peak heart rate and cardiac output are blunted at maximal exercise, while there is less muscle fatigue at the point of exhaustion, suggesting early limitation of motor drive and disengagement from the effort before the advent of important peripheral muscle fatigue (Kayser 2003; Amann et al. 2007; Amann and Kayser 2009; Seifert et al. 2010; Subudhi et al. 2011) .
near infrared spectroscopy (nIrS) allows for the continuous measure of oxy-and deoxyhemoglobin concentrations in brain tissue thus potentially giving precious information on the oxygenation status during exercise and exposure to hypoxia (Bourdillon and Perrey 2012). Exposure to hypoxia at rest lowers prefrontal cortex tissue oxygenation, while global exercise in normoxia elevates it (rupp and Perrey 2008; Smith et al. 2012) . Since combination of global exercise and hypoxia reduces cerebral tissue oxygenation (rupp and Perrey 2008; Subudhi et al. 2008; Bourdillon et al. 2009; Verges et al. 2012) , some authors speculated that this reduction might limit global exercise capacity and performance in hypoxia (Amann et al. 2007; Subudhi et al. 2009; Amann and Kayser 2009; rasmussen et al. 2010) . In agreement with this contention, during exercise in severe hypoxia, administration of supplemental oxygen at the point of exhaustion rapidly improves cerebral oxygenation, improving peak power output (Subudhi et al. 2009; Koglin and Kayser 2013 ) and time to exhaustion (Kayser et al. 1994; Amann et al. 2007) . Since this shift is too quick to result from reversal of the accrual or depletion of metabolites associated with muscle fatigue, it was suggested that the improvement in performance may be mediated by improved cerebral oxygen delivery (Kayser et al. 1994; Amann et al. 2007; Subudhi et al. 2009) .
cerebral oxygen delivery is the product of cerebral blood flow (cBF) and caO 2 . In normoxia, submaximal global exercise increases middle cerebral artery blood velocity (McAv) and presumably blood flow (Jørgensen et al. 1992; Madsen et al. 1993; Ide et al. 1999) . Hypoxemia per se leads to cerebral vasodilation, while hyperventilationinduced hypocapnia associated with hypoxemia causes cerebral vasoconstriction (Ainslie and Ogoh 2010) . the net effect of exposure to hypoxia on cBF depends on the sum of these opposing drives (Peltonen et al. 2007; nishimura et al. 2010) . Whether cBF and cerebral oxygenation play a limiting role in exercise performance in hypoxia remains unclear (Subudhi et al. 2008; Peltonen et al. 2009; Subudhi et al. 2011; Verges et al. 2012; .
the extent of hypoxemia and hypocapnia upon acute exposure to hypoxia is function of the hypoxic ventilatory response, defined as the increase in ventilation in hypoxic conditions, through the stimulation of the peripheral chemoreceptors. For acclimatization to high altitude and mountaineering performance, a strong hypoxic ventilatory response (i.e., large increase in ventilation) is thought to be a factor for success, but may also increase the risk of brain damage because of excessive hyperventilation hypocapniainduced cerebral hypoxemia (Hornbein et al. 1989) . In contrast, findings by Bernardi et al. (2006) suggest that a blunted ventilatory response to hypoxia gives acclimatized elite climbers more respiratory reserve, which would allow them to perform better at extreme altitude.
richalet et al. (1983, 2012 ) developed a hypoxia sensitivity test and reported that a blunted cardiorespiratory response to hypoxia during cycling exercise (at an intensity reaching a heart rate of ~130 bpm in normoxia) predicts risk for acute mountain sickness (AMS). cBF and cerebral tissue oxygenation responses during this test have not yet been reported. We hypothesized that a brisk cBF response during a richalet test would protect cerebral tissue oxygenation and be accompanied by less impairment of cycling time-trial performance in severe hypoxia, while a brisk ventilatory response to hypoxia would impede cerebral oxygenation and impair time-trial performance. to test these hypotheses, we measured cBF with transcranial Doppler and prefrontal cerebral cortex oxygenation with nIrS during a richalet test in unacclimatized subjects and related the changes with the subjects' all-out 15 km timetrial (tt) cycling performances in normoxia and acute normobaric hypoxia.
Methods
Participants thirteen healthy male subjects participated in this study [age: 27 ± 7 years (mean ± SD); body mass index: 22.3 ± 1.3 kg/m 2 , and Wmax: 385 ± 30 W]. All were trained amateur cyclists living in geneva, Switzerland (389-450 m) and not acclimatized to high altitude. they were non-smokers, had no previous history of cardiovascular, cerebrovascular, or respiratory disease and were not taking any medication at the time of the study. Informed written consent was obtained from the subjects prior to their participation. the study was approved by the research Ethical committee of the University Hospitals of geneva and conformed to the standards set by the Declaration of Helsinki.
Experimental design
In the context of another study ) the participants had three laboratory visits. the first visit included familiarization (which included adjustment of bike settings and familiarization with all devices and procedures used for the experiments), and the richalet hypoxia sensitivity test (described below), followed by an incremental ramp test on a cycle ergometer (Ergoselect 100, Ergoline gmbH, Bitz, germany). the participants then returned on two separate days to perform a 15 km tt in either normoxia (ambient air at 389 m) or hypoxia (normobaric, FIO 2 = 0.11, equivalent of an altitude of ~5,000 m) in a randomized, balanced, single-blind design. the tests were separated by three to fourteen days. Before each experimental session, the participants were asked to abstain from caffeine for 12 h, and heavy exercise and alcohol for 24 h. Each time-trial session comprised of 20 min of instrumentation followed by a 2-min resting baseline collection with the participants breathing room air. they were seated on a racing bicycle fitted to a computrainer Pro model trainer (racerMate, Seattle, WA, USA), which was calibrated prior to each session according the manufacturers' instruction manual. While breathing room air, the subjects were asked to perform a 5-min self-selected warm-up exercise with heart rate <130 bpm. they then rested for 5 min after which they were switched to breathe from a gas mixing system (Altitrainer, SMtec, nyon, Switzerland) for another 4-min resting baseline collection. the participants were instructed to perform a 15 km tt cycling as fast as possible. they were free to shift gears during tt and constant feedback regarding the distance was provided on a monitor by means of a cursor along a horizontal bar and a countdown distance display (computrainer 3D software version 3.0, racermate). time-trial performance was expressed as the time spent to cover the 15 km as well as the average power output during the tt. throughout all three experimental sessions, the participants wore a nose-clip and breathed through a mouthpiece attached to a low resistance one-way non-rebreathing valve (Hans-rudolph 2700, Kansas city, MO, USA). Hypoxia was achieved attaching the gas mixing system to the inspiratory valve of the mouthpiece using low resistance tubing. the device consists of a reservoir in which air and experimental gasses are mixed and from which the participant inspires. During the time-trials the fraction of inspired O 2 (FIO 2 ) was kept constant at either 0.21 or 0.11, corresponding to sea level and an altitude of 5,000 m, respectively. the participants always breathed through the same circuit, were kept naive to what gas mixture they were breathing, and were not informed in detail about the rationale of the study. For each participant, the experiments were carried out at the same time of day under consistent laboratory conditions (temperature 21 ± 1 °c, humidity 32 ± 5 %, barometric pressure 726 ± 6 mmHg). richalet test Figure 1 shows the richalet hypoxia sensitivity test (richalet et al. 2012 ) of which we performed the four 4-min steps: (a) resting normoxia (rn); (b) resting hypoxia (rH; FIO 2 = 11 %); (c) hypoxic exercise (EH); and (d) normoxic exercise (En). Mechanical power output on the cycle ergometer was adjusted at the beginning of the first cycling phase to attain a heart rate (Hr) at around 120-130 bpm in hypoxia and then kept constant (corresponding to 37 ± 7 % of maximal normoxic power output). Arterial oxygen saturation from pulse oximetry (SpO 2 ), ventilation (V E) and Hr variations between phases were used to characterize subjects' sensitivity to hypoxia (richalet et al. 2006, 2012) by calculating:
Desaturation at rest: ∆Sp r = Sp rn − Sp rh (%) Desaturation at exercise: ∆Sp e = Sp en − Sp eh (%) Ventilation changes at rest: ∆VE r =V E rh −V E rn (1/min); Ventilation changes at exercise: ∆V E e =V E eh −V E en (1/min); RN rest in normoxia, RH rest in hypoxia, EH exercise in hypoxia, EN exercise in normoxia. Hypoxia was produced by breathing a normobaric hypoxic gas mixture (FIO 2 = 0.115). Exercise was performed at approximately 37 ± 7 % of maximal power output in phases EH and En. Ventilatory response to hypoxia during exercise (HVr e ); Arterial oxygen saturation (Sa, SaO 2 ); Arterial oxygen saturation during rest (Sa e ); Arterial oxygen saturation during exercise (Sa r ); pulmonary ventilation (V E e ); Pulmonary ventilation during exercise (V E e ). Ventilatory response at rest:
Ventilatory response at exercise: HVR e = ∆V E e /∆Sp e /BW (l/min/kg); cardiac response at rest: HCR r = (HR rh −HR rn )/∆Sp r (beats/min/ %); cardiac response during exercise: HCR e = (HR eh −HR en )/∆Sp r (beats/min/ %). Sp = O 2 saturation, Hr = heart rate, V E = ventilation, BW = body weight, r = rest, e = exercise, n = normoxia, h = hypoxia.
Measurements

Respiratory variables
gas exchange was monitored breath-by-breath (Medgraphics cPX, St Paul, Mn, USA) measuring flow at the mouth (Pitot tube). Fractions of inspired and expired O 2 and cO 2 were recorded with fast responding gas analysers (infrared and paramagnetic) integrated in the system. Ventilation was calculated from the flow signal and expressed in l.min
BtPS. Partial pressures of end-tidal O 2 (PetO 2 ) and cO 2 (PetcO 2 ) were also measured by the gas analysis system. Prior to each experimental session, the system was calibrated using a 3-l syringe (M9474, Medikro Oy, Finland) and gas mixtures of known O 2 and cO 2 concentrations.
Cerebrovascular variables
Middle cerebral artery blood flow velocities (McAv) were measured bilaterally using a 2-MHz pulsed Doppler ultrasound system (St3, Spencer technology, Seattle, WA, USA). the probes were positioned over the temporal windows and held firmly in place with an adjustable head frame (Marc 600, Spencer technology, Seattle, WA, USA). the signals were acquired at depths ranging from 43 to 54 mm. Signal quality was optimized and an M-mode screen shot was recorded to facilitate subsequent probe placements. Depth and velocity of McAv signals were recorded and compared between sessions to ensure withinsubject repeatability. In our hands, day-to-day reproducibility of McAv has a coefficient of variation of <10 %. Bilateral McAv were averaged to represent an index of overall cBF. cerebral oxygenation in the left prefrontal lobe was assessed by monitoring changes in oxy-, deoxyand total hemoglobin (O 2 Hb, HHb and tHb, respectively), obtained with spatially resolved, continuous wave nIrS (Artinis, Oxymon MKIII, Zetten, the netherlands). the nIrS probe was centered on the Fp1 point according to the EEg 10-20 system, i.e., 10 % of the nasion-vertex-inion distance, up from the nasion; and 10 % of the nasion-temporal-inion distance, left from the nasion. nIrS measures changes in infrared light attenuation diffusing through tissue. Positioned over the scalp, this non-invasive device allows monitoring of regional changes in cerebral hemodynamics and reflects local tissue oxygenation. the signals reflect variations in concentrations of O 2 Hb, HHb and tHb in brain blood vessels (arterioles, capillaries, venules and veins), not O 2 in the tissue itself. Source-detector spacing was set at 4.1 cm and data obtained from the optode was used to calculate changes with regard to baseline resting conditions in O 2 Hb, HHb and tHb with a differential path length factor computed according to the subjects' age (van der Zee et al. 1992 ). All reported concentrations of O 2 Hb, HHb and tHb are changes with regard to normoxic resting baseline. For the richalet test the resting baseline was set at 0 during the rn phase.
Cardiovascular variables
Beat-to-beat mean arterial blood pressure (MAP) was monitored using finger photoplethysmography (Finometer-MIDI, Finapress Medical Systems, Amsterdam, the netherlands). From the MAP traces, beat-to-beat Hr was calculated (labchart version 7.2, ADInstruments, Bella Vista, Australia). Peripheral O 2 saturation (SpO 2 ) was measured with a pulse oximeter (radical-7™, Masimo corporation, Irvine, cA, USA) on the right earlobe after application of a hyperaemia-inducing ointment (Decontractyl, SanofiAventis, Paris, France). Arterialized blood gas samples of 75 μl were taken from the other ear lobe of the subjects during baseline, and at the 5th, 10th and 15th km of the tt. Samples were immediately analyzed on a rapidlab 248 (Siemens, Erlangen, germany) for PaO 2 , PacO 2 , and pH, with [HcO 3-] and SaO 2 calculated by the system. Data were acquired using an analogue-to-digital converter (Ml880, Powerlab 16/30, ADInstruments, Bella Vista, Australia) with commercially available software (labchart version 7.2, ADInstruments, Bella Vista, Australia), and stored on a computer for analysis. With the exception of the blood samples, all variables were recorded continuously at 200 Hz throughout the richalet test and the 15 km tt tests.
Data and statistical analysis
From the richalet tests the average data obtained in the last 30 s of the 4-min phases were used. Data are reported as mean ± SD. A paired t test (p < 0.05) was used to compare normoxic and hypoxic 15 km time-trial times, average power output, Hr and SpO 2 . repeated-measures AnOVA with an alpha level of p < 0.05 were used to compare the 30 s means at each kilometer of the tt for these variables (Matlab r2013b, MathWorks ® , natick, MA, USA). Differences between phases of the richalet test were also assessed using repeated-measures AnOVA with an alpha level of p < 0.05. Post hoc analysis of significant results from the AnOVAs was performed through Fischer's lSD. correlation between variables was quantified by Pearson product (R = σxy/(σx. σy) with σxy covariance between parameters x and y; σx and σy standard deviations of parameters x and y) using Matlab.
Results
the main parameters during the four phases of the richalet test are summarized in Fig. 2 and typical traces of McAv and nIrS variables are shown in Fig. 3 . resting hypoxia tended to increase V E (p > 0.05), while normoxic exercise, corresponding to 37 ± 7 % of maximum aerobic work capacity in normoxia, increased it by 22 ± 7 l/min (12 ± 3 vs. 34 ± 5 l/min, p < 0.05); hypoxic exercise furthered this increase by 36 ± 10 l/min (12 ± 3 vs. 48 ± 9 l/min, p < 0.05 vs. resting normoxia, Fig. 2a ). Hypoxia at rest lowered SpO 2 by 11 ± 3 % (p < 0.05 vs. resting normoxia). the normoxic exercise did not decrease SpO 2 (p > 0.05 vs. resting normoxia), while hypoxic exercise lowered SpO 2 by 27 ± 5 % (p < 0.05, Fig. 2b ). resting hypoxia tended to increase Hr by 11 ± 4 bpm (p > 0.05); Hr was increased by 36 ± 10 bpm during normoxic exercise (p < 0.05 vs. resting normoxia), while the hypoxic exercise increased Hr by 55 ± 9 (p < 0.05 vs. resting normoxia, Fig. 2c ). the patterns of change of those three parameters corresponded to those described by richalet et al. (2006, 2012) .
resting hypoxia decreased PetcO 2 by 3.6 ± 1.2 mmHg (p < 0.05), while normoxic exercise increased PetcO 2 by 5.5 ± 1.9 mmHg (p < 0.05). Hypoxic exercise did not change PetcO 2 as compared to resting hypoxia (p > 0.05, Fig. 2h ).
Mean BP was modified by exercise only (p < 0.05), while hypoxia had no effect (p > 0.05, Fig. 2i ).
Mean McAv was unaltered with resting hypoxia (p > 0.05), while it was increased during normoxic exercise (by 22 ± 12 %, p < 0.05) and to an even greater extent during hypoxic exercise (by 33 ± 17 %, p < 0.05, Figs. 2g  and 3) . the nIrS data for one subject were lost due to a technical issue (n = 12). O 2 Hb followed the same trend as SpO 2 , decreasing by 2.2 ± 1.2 μmol in resting hypoxia (p < 0.05), while hypoxic exercise during the richalet test further lowered cerebral O 2 Hb to −7.6 ± 3.1 μmol from baseline (p < 0.05, Figs. 2d, 3) . In contrast, normoxic exercise had no effect on cerebral O 2 Hb (p > 0.05). cerebral HHb showed mirror changes compared to cerebral O 2 Hb, increasing by 3.5 ± 1.8 μmol in hypoxic rest (p < 0.05 vs. normoxic rest). Hypoxic exercise increased cerebral HHb by 8.5 ± 2.9 μmol (p < 0.05), while normoxic exercise had no effect (p > 0.05, Figs. 2e, 3) . cerebral tHb did not change throughout the four phases of the richalet test (Fig. 2f) . Mean HVr e was 0.77 ± 0.41 l/min/kg and mean HVr r was 0.50 ± 0.51 l/min/kg. none of our subjects were below richalet's thresholds for normal values (richalet et al. 2006) . neither HVr e nor HVr r correlated with the performance decrement in hypoxic tt (R = 0.12, 0.08 respectively, p > 0.05 for both).
SpO 2 and McAv correlated well during the hypoxic phases of the richalet test (rH vs. EH, r = −0.77, p < 0.05, Fig. 4 ).
there were good correlations for the McAv and cerebral HHb changes between normoxic and hypoxic exercise (R = 0.76, p < 0.05, n = 12, Fig. 5b ) and between hypoxic rest and hypoxic exercise (R = 0.76, p < 0.05, n = 12, Fig. 5a ) during the richalet test. A similar trend was found for SpO 2 and cerebral HHb between normoxic versus hypoxic exercise (R = −0.64, p = 0.05, n = 12) and between hypoxic rest and hypoxic exercise (R = −0.76, p < 0.05 n = 12).
time to complete the 15 km increased in hypoxia by 20.2 ± 6.2 % (1,904 ± 75 s vs. 1,581 ± 60 s; p < 0.05).
SaO 2 at the 5th, 10th, and 15th km, along with Hr, and power output at each kilometer during the tt in normoxia and hypoxia are reported on Fig. 6 (n = 11, due to difficulties in blood sampling from two subjects). Hr was higher at rest in hypoxia (p < 0.05), but lower during the last 3 km of the trials (p < 0.05). Power output and SaO 2 were lower in hypoxia at all times (p < 0.05 for both). Figure 7a shows the correlation between the mean drop in SaO 2 and the drop in performance during the 15 km tt (R = 0.64, p < 0.05, n = 11). Figure 7b shows the correlation between mean brain HHb during the tt and the drop in performance (R = 0.62, p < 0.05). there was no Fig. 3 Fig. 4 correlation between changes in O 2 saturation and cerebral blood flow velocity during the RH resting hypoxia and the EH hypoxic exercise phases of the richalet test (cf. Fig. 1 ). Pulse oxygen saturation (SpO 2 ); Middle cerebral artery blood flow velocity (McAv) correlation between mean McAv during the tt and the drop in performance.
Discussion
the variations in SpO 2 , McAv and prefrontal brain HHb between the phases of the richalet test correlated with each other, but not with the tt performance decrement in hypoxia, which refutes our first hypothesis. there was also no correlation between the hypoxic ventilatory response as quantified by the richalet test (HVr r and HVr e ) and the impairment of tt performance, which refutes our second hypothesis. conversely, the changes in SaO 2 and of prefrontal brain HHb during the tt were correlated with the drop in tt performance, suggesting that mass oxygen supply to the brain during the tt was limited by the exposure to hypoxia, thus leaving the hypothesis that brain oxygenation may play a limiting role for global exercise in conditions of severe hypoxia to be tested further.
cerebral blood flow and oxygenation during the richalet test Prefrontal cortex O 2 Hb was decreased by hypoxia and further reduced with exercise and hypoxia combined (Figs. 2d,  3 ). this reduction in O 2 Hb coincided with increased prefrontal HHb while tHb remained unchanged (Fig. 2f) , indicating reduced prefrontal cortex oxygenation (Figs. 2d-f, 3 ). McAv and HHb correlated during the richalet test (Fig. 5a, b) . Since the nIrS data consistently showed reduced oxygenation during hypoxic exercise, the increase in cBF (as estimated by McAv) was insufficient to prevent the drop in cerebral tissue oxygenation. As suggested by Verges et al. (2012) , the balance between O 2 delivery and utilization in the prefrontal cortex was probably modified towards a lower level of oxygenation during exercise in hypoxia. the reduction in cerebral O 2 delivery, potentially associated with an increased cerebral metabolic rate during whole-body exercise in hypoxia ), would thus account for the reduced O 2 Hb. However, since nIrS assesses changes in deoxygenation in both pre-and post-capillary areas, it is also possible that oxygen extraction might have been increased (Brugniaux et al. 2007; Smith et al. 2013) .
the changes in McAv and nIrS variables during the richalet test did not correlate to tt performance. Profound hypoxemia (SaO 2 < 75 %) is thought to limit performance through a shift from predominantly peripheral muscle fatigue towards a cnS based inhibitory effect on central motor drive (Amann et al. 2007; Amann and Kayser 2009; rasmussen et al. 2010) . It is likely that the limited hypoxemia during the richalet test was of insufficient magnitude to limit central motor output. Moreover, the intensity of exercise during the richalet test, corresponding to ~50-60 % of peak hypoxic aerobic capacity, probably did not sufficiently challenge mass oxygen transport to muscle and brain. As such, subjects with a greater decrease in SpO 2 during the richalet test showed a greater increase in McAv and HHb (Figs. 4, 5 ), but these changes do not provide insight to the variations in McAv and HHb up to maximal exercise, nor do they predict tt performance decrease in hypoxia.
We found no correlation between PetcO 2 and other variables in our study, probably because the decrease in PetcO 2 in hypoxia was too small (Fig. 2h) to provoke a significant vasoconstriction in the cerebral vasculature. the increase in McAv associated with hypoxia, increased cardiac output and systemic blood pressure during exercise would also counteract the vasoconstrictive effect of reduced PetcO 2 .
Although McAv and cerebral nIrS variables during the richalet test were not predictive of performance, these variables are of interest in order to characterize the cBF response to hypoxia, which is normally difficult to test, as cBF is normally insensitive to acute hypoxia during rest, unless hypoxia is very severe (PetO 2 < 50 mmHg). Further studies are needed to determine whether specific nIrS or McAv responses to hypoxia would be predictive of altitude sickness.
Exercise limitation in severe hypoxia the impairment of aerobic power and exercise performance in severe hypoxia (SaO 2 < 75, 66 % in the present study) is still not well understood (Amann et al. 2007; ). While the lack of oxygen is the obvious cause, the exact mechanisms by which hypoxia initiates an earlier disengagement from an exercise challenge remain unclear. Since biochemical, electromyographic, and mechanical signs of muscle fatigue at exhaustion are lower compared to normoxia, muscle metabolic fatigue does not appear to be the main cause of impaired whole-body exercise performance in severe hypoxia (Verges et al. 2012) . Upon reaching exhaustion in severe hypoxia, subjects can continue cycling when surreptitiously switched to normoxia and/or hyperoxia (Kayser et al. 1994; Amann et al. 2007; Subudhi et al. 2008; Koglin and Kayser 2013) , which supports the role of supra-spinal limitation in exercise performance. Amann et al. (2007) speculated that the degree of hypoxia influences the relative role of muscle fatigue in the cessation of dynamic exercise with large muscle groups. they noted that similar levels of muscle fatigue were observed at task failure from constant load exercise to exhaustion, when SaO 2 averaged 94, 82, or 76 %, respectively (FIO 2 = 0.21-0.12), but less muscle fatigue at a SaO 2 of 67 % (FIO 2 = 0.10). From this, they reasoned that there is a threshold of SaO 2 for a switch from a predominant effect of peripheral fatigue to a predominant effect in the cnS. In the present study both SaO 2 and HHb concentrations during the 15 km tt correlated to performance in hypoxia. Since SaO 2 during the tt dropped well below the 75 % threshold proposed by Amann et al. (2007) , tt performance was likely curtailed by some degree of cnS based limitation to motor drive. Since nIrS variables reflect a mean between pre-and post-capillary states, therefore potentially including mechanisms for O 2 extraction, there might be a role of adaptive oxygenation fraction extraction in hypoxia.
In similar conditions of severe hypoxia (SaO 2 < 75 %), calbet et al. (2009) found that the reduction in systemic and leg O 2 delivery during cycling corresponded with the reduction in V O 2 peak. Since V O 2 peak was reached at submaximal cardiac output as compared to normoxia, they speculated that the impaired maximal cardiac output, leg blood flow, O 2 delivery to the leg muscles, and subsequent reduced V O 2 peak and exercise performance could be attributed to a cardio-inhibitory reflex associated with lower brain O 2 delivery in severe acute hypoxia.
In agreement with this hypothesis we found a decrease in brain oxygenation in our setup and a correlation between the change in prefrontal brain HHb between normoxic and hypoxic tt and the drop in tt performance (Fig. 7b) . However, we found no significant correlation between the changes in McAv and performance. the latter might be due to the strong increase in McAv during intense exercise, equally in normoxia and hypoxia. We recently reported that augmenting FIcO 2 led to an increase in cBF during submaximal exercise in normoxia, but not in hypoxia, indicating that the 'normal' cerebrovascular response to hypercapnia (i.e., vasodilation) is blunted during exercise in hypoxia, possibly due to an exhaustion of cerebral vasodilatory reserve . If severe hypoxia cannot increase McAv further than that resulting from intense exercise, it may explain the lack of correlation between hypoxic-normoxic McAv differences and tt performance.
Hypoxic ventilatory response and performance at altitude Schoene et al. (1984) reported that climbers with a strong hypoxic ventilatory response were more successful on Everest, reaching and sleeping at higher altitudes. Meanwhile, Bernardi et al. (2006) measured the ventilatory response to hypoxia in 11 elite climbers attempting Everest and K2 and found that the successful climbers (i.e., those summiting without using bottled oxygen) had lower resting minute ventilation, respiratory rate, and ventilatory response to hypoxia, and higher ventilatory reserve and ventilatory efficiency at 5,200 m, compared to the non-summiteers. those authors concluded that a blunted hypoxic ventilatory response at moderate altitude was advantageous for these summiteers, as it meant that they had a greater ventilatory reserve at lower altitudes, thereby permitting more sustainable ventilations near the summits. Since there was no difference in the hypoxic ventilatory response at low altitude prior to acclimatization, it appears that this blunted ventilation at altitude was likely to be an adaptive response rather than a constitutive characteristic (Bernardi et al. 2006) . Additionally, Hornbein et al. (1989) suggested that a strong ventilatory response may lead to such important drops in PacO 2 that hypocapnic cerebral vasoconstriction dominates hypoxic vasodilation, leading to excessive tissue hypoxia, and impaired neurobehavioral function and residual effects upon return from a prolonged altitude exposure. Van Dorp et al. (2007) found improved cognitive performance in hypoxia when adding cO 2 to inspirate, suggesting that the balance between hypoxia-induced vasodilation and hypocapnia-induced vasoconstriction is indeed important. In the present study, the hypoxic stimulus was unlikely to be strong enough to reach ventilatory reserve and the intensity of exercise during the richalet test was not sufficient to obtain a convincing correlation between the variations in SpO 2 and V E or HVr e as defined by richalet et al. (2012) . limitations the richalet test was originally designed to predict susceptibility for altitude illness (richalet et al. 2012) . In predisposed subjects and those who ascend too quickly, AMS develops between four and height hours after arrival to altitudes above 2,500-3,500 m (Hackett et al. 1976 ). In our experimental design, the tt was performed after about 5 min of exposure to normobaric hypoxia, which is too short for AMS symptoms to develop. Whether cBF and brain oxygenation reactivity during a richalet test relate to AMS during a prolonged stay at altitude remains an open question. the relationship between richalet test results and the risk for AMS was evaluated on thousands of measurements (richalet et al. 2012) . Because of the limited number of subjects in our study we cannot exclude the possibility that the lack of correlation between cBF and cerebral oxygenation indices during the richalet test with time-trial performance might be due to type-II error.
We opted to use the original richalet test altitude of 4,800 m but tested performance at 5,000 m. According to the measured FIO 2 the actual difference between the two simulated altitudes was 165 m. Since the richalet test yields the same outcome at different simulated altitudes this should not have influenced the results (richalet et al. 2012) .
We used left prefrontal HHb and O 2 Hb measured by nIrS as indicators of global cerebral tissue oxygenation, which is a simplification, even though good agreements have been found between nIrS and fMrI measurements of cerebral tissue oxygenation levels over various cortices (Kleinschmidt et al. 1996; Strangman et al. 2002) . nIrS bears further limitations (Bourdillon and Perrey 2012) such as bias from skin blood flow variations, since the light traverses the skin and the bone layers before entering the tissue of interest. According to tew et al. (2010) such changes due to skin effects can be considered negligible compared to the changes in the brain tissue.
Since the two McAs supply ~80 % of global cBF (lindegaard et al. 1987) , we used transcranial Doppler ultrasound to measure bilateral McAv as an index of global cBF changes. McAv has been shown to reflect changes in cBF assessed with the direct Fick method during initial exposure to high altitude (roy et al. 1968) . Sato et al. (2012) found good agreement between McAv and internal carotid artery blood flow changes (measured by duplex ultrasonography) during exercise from moderate (60 % V O 2 peak) to high intensity (80 % V O 2 peak). they further demonstrated that the relative contribution of the internal carotid artery (and therefore McA) to global cBF remained relatively unchanged (~65 %) at high intensity exercise. As such, we contend that McAv is a reasonable index of changes in global cBF from rest to heavy exercise. nevertheless, we cannot exclude variations between different areas of the brain.
During the richalet test and the tt we measured SpO 2 with an oximeter. Only during the tt we repeatedly measured SaO 2 in capillary earlobe blood samples. Since during the tt SpO 2 dropped below 65 %, below the range in which values are reliable (70 to 100 % following the manufacturer's instructions), we used SaO 2 , collected at rest and at 5th, 10th, and 15th km of the tt. SaO 2 was not corrected for temperature changes during the tt; however, an increase in body core temperature from 37 to 39 °c during exercise would only have modified SaO 2 from 0.968 to 0.970 in normoxia and from 0.640 to 0.641 in hypoxia [estimations made using the OSA program, (SiggaardAndersen 1974 (SiggaardAndersen , 2003 ].
Perspectives there may be a trade-off between aerobic performance at moderate high altitude and extreme altitude, the former improving with a brisk ventilatory response to hypoxia, the latter with a blunted response. It would therefore be interesting to relate the routine results of the richalet test not only to altitude illness but also to altitude performance (for example highest altitude reached, summit success) and to complement the test with cBF, frontal lobe nIrS measurements and cognitive performance tests, if possible repeated upon return from altitude.
Conclusions
We found that the results of the richalet test were not predictive of the impairment of 15 km time-trial cycling performance in severe hypoxia. Since the hypoxia-caused decrease in SaO 2 and in prefrontal brain HHb during the tt correlated with the decrease in tt performance, mass oxygen supply to the brain during the tt seemed limited by hypoxia, leaving the hypothesis that brain oxygenation may play a limiting role for global exercise in conditions of severe hypoxia to be tested further.
